Dr. Richard Boughal, MD

NPI: 1447328059
Total Payments
$756.92
2023 Payments
$71.86
Companies
17
Transactions
44
Medicare Patients
3,922
Medicare Billing
$364,879

Payment Breakdown by Category

Food & Beverage$756.92 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $756.92 44 100.0%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $124.60 8 $0 (2022)
Novo Nordisk Inc $110.59 6 $0 (2022)
Daiichi Sankyo Inc. $74.42 4 $0 (2021)
PFIZER INC. $66.30 5 $0 (2021)
Janssen Pharmaceuticals, Inc $53.02 3 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $49.12 3 $0 (2022)
AstraZeneca Pharmaceuticals LP $45.01 3 $0 (2021)
ABBVIE INC. $42.22 2 $0 (2022)
Novartis Pharmaceuticals Corporation $34.61 2 $0 (2022)
Lilly USA, LLC $31.63 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $71.86 3 Lilly USA, LLC ($31.63)
2022 $194.36 11 Novo Nordisk Inc ($74.43)
2021 $248.96 15 GlaxoSmithKline, LLC. ($80.00)
2020 $121.28 7 AstraZeneca Pharmaceuticals LP ($30.30)
2019 $59.69 4 PFIZER INC. ($24.51)
2018 $16.82 1 Janssen Pharmaceuticals, Inc ($16.82)
2017 $43.95 3 PFIZER INC. ($27.95)

All Payment Transactions

44 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/25/2023 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $31.63 General
Category: Diabetes
03/23/2023 SANOFI PASTEUR INC. FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE Food and Beverage In-kind items and services $24.28 General
Category: Vaccines
01/24/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $15.95 General
Category: INSOMNIA
11/03/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.48 General
Category: Diabetes
09/23/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $20.00 General
Category: NEUROSCIENCE
09/14/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.88 General
Category: Gastroenterology
07/28/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.40 General
Category: Diabetes
07/08/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.95 General
Category: Gastroenterology
05/06/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $22.21 General
Category: CARDIOVASCULAR
04/08/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $21.17 General
Category: Diabetes
04/06/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.29 General
Category: Gastroenterology
02/25/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.00 General
Category: RESPIRATORY
01/25/2022 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $20.38 General
Category: Diabetes
01/21/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.60 General
Category: RESPIRATORY
12/17/2021 Novo Nordisk Inc RYBELSUS (Drug), Ozempic Food and Beverage In-kind items and services $20.23 General
Category: Diabetes
11/16/2021 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $15.36 General
Category: Iron Deficiency Anemia
11/12/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.00 General
Category: RESPIRATORY
11/05/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $22.22 General
Category: NEUROSCIENCE
10/05/2021 Althera Pharmaceuticals LLC Roszet (Drug) Food and Beverage In-kind items and services $11.69 General
Category: Cardiovascular
10/01/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.00 General
Category: RESPIRATORY
09/03/2021 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $15.57 General
Category: Iron Deficiency Anemia
08/24/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.20 General
Category: Cardiovascular & Metabolism
08/13/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.00 General
Category: RESPIRATORY
07/09/2021 PFIZER INC. ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS Food and Beverage In-kind items and services $13.84 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/22/2021 Astellas Pharma US Inc MYRBETRIQ (Drug) Food and Beverage In-kind items and services $19.21 General
Category: UROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 890 1,559 $164,295 $90,650
2022 15 1,019 1,658 $163,175 $91,223
2021 13 1,040 1,729 $178,375 $100,314
2020 15 973 1,780 $176,632 $82,692
Total Patients
3,922
Total Services
6,726
Medicare Billing
$364,879
Procedure Codes
54

All Medicare Procedures & Services

54 procedure records from CMS Medicare Utilization — Page 3 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
94640 Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen Office 2020 12 13 $650.00 $183.57 28.2%
82270 Stool analysis for blood to screen for colon tumors Office 2020 20 20 $300.00 $87.60 29.2%
81002 Urinalysis, manual test Office 2020 17 18 $450.00 $62.43 13.9%
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg Office 2020 12 39 $975.00 $1.00 0.1%

About Dr. Richard Boughal, MD

Dr. Richard Boughal, MD is a Internal Medicine healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447328059.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Boughal, MD has received a total of $756.92 in payments from pharmaceutical and medical device companies, with $71.86 received in 2023. These payments were reported across 44 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($756.92).

As a Medicare-enrolled provider, Boughal has provided services to 3,922 Medicare beneficiaries, totaling 6,726 services with total Medicare billing of $364,879. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Northport, NY
  • Active Since 12/01/2006
  • Last Updated 12/26/2013
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1447328059

Products in Payments

  • TRELEGY ELLIPTA (Drug) $76.60
  • Rybelsus (Drug) $74.43
  • INJECTAFER (Drug) $74.42
  • XARELTO (Drug) $53.02
  • XIFAXAN (Drug) $49.12
  • ANORO ELLIPTA (Drug) $48.00
  • ENTRESTO (Drug) $34.61
  • JARDIANCE (Drug) $31.63
  • FARXIGA (Drug) $30.30
  • ELIQUIS (Drug) $25.29
  • JANUVIA (Drug) $24.73
  • CHANTIX (Drug) $24.51
  • FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $24.28
  • UBRELVY (Drug) $22.22
  • RYBELSUS (Drug) $20.23
  • QULIPTA (Drug) $20.00
  • MYRBETRIQ (Drug) $19.21
  • VFEND (Drug) $16.50
  • Vascepa (Drug) $16.29
  • QUVIVIQ (Drug) $15.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Northport